Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 2
2011 1
2012 3
2013 6
2014 7
2015 2
2016 3
2017 4
2018 5
2019 4
2020 3
2021 5
2022 6
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Results by year

Filters applied: . Clear all
Page 1
Effects of Dietary Fibers on Short-Chain Fatty Acids and Gut Microbiota Composition in Healthy Adults: A Systematic Review.
Vinelli V, Biscotti P, Martini D, Del Bo' C, Marino M, Meroño T, Nikoloudaki O, Calabrese FM, Turroni S, Taverniti V, Unión Caballero A, Andrés-Lacueva C, Porrini M, Gobbetti M, De Angelis M, Brigidi P, Pinart M, Nimptsch K, Guglielmetti S, Riso P. Vinelli V, et al. Among authors: taverniti v. Nutrients. 2022 Jun 21;14(13):2559. doi: 10.3390/nu14132559. Nutrients. 2022. PMID: 35807739 Free PMC article. Review.
Collinsella aerofaciens as a predictive marker of response to probiotic treatment in non-constipated irritable bowel syndrome.
Gargari G, Mantegazza G, Cremon C, Taverniti V, Valenza A, Barbaro MR, Marasco G, Duncan R, Fiore W, Ferrari R, De Vitis V, Barbara G, Guglielmetti S. Gargari G, et al. Among authors: taverniti v. Gut Microbes. 2024 Jan-Dec;16(1):2298246. doi: 10.1080/19490976.2023.2298246. Epub 2024 Jan 4. Gut Microbes. 2024. PMID: 38178601 Free PMC article. Clinical Trial.
Fecal short-chain fatty acids in non-constipated irritable bowel syndrome: a potential clinically relevant stratification factor based on catabotyping analysis.
Gargari G, Mantegazza G, Taverniti V, Gardana C, Valenza A, Rossignoli F, Barbaro MR, Marasco G, Cremon C, Barbara G, Guglielmetti S. Gargari G, et al. Among authors: taverniti v. Gut Microbes. 2023 Dec;15(2):2274128. doi: 10.1080/19490976.2023.2274128. Epub 2023 Nov 1. Gut Microbes. 2023. PMID: 37910479 Free PMC article.
Postbiotics - when simplification fails to clarify.
Aguilar-Toalá JE, Arioli S, Behare P, Belzer C, Berni Canani R, Chatel JM, D'Auria E, de Freitas MQ, Elinav E, Esmerino EA, García HS, da Cruz AG, González-Córdova AF, Guglielmetti S, de Toledo Guimarães J, Hernández-Mendoza A, Langella P, Liceaga AM, Magnani M, Martin R, Mohamad Lal MT, Mora D, Moradi M, Morelli L, Mosca F, Nazzaro F, Pimentel TC, Ran C, Ranadheera CS, Rescigno M, Salas A, Sant'Ana AS, Sivieri K, Sokol H, Taverniti V, Vallejo-Cordoba B, Zelenka J, Zhou Z. Aguilar-Toalá JE, et al. Among authors: taverniti v. Nat Rev Gastroenterol Hepatol. 2021 Nov;18(11):825-826. doi: 10.1038/s41575-021-00521-6. Nat Rev Gastroenterol Hepatol. 2021. PMID: 34556825 Free article. No abstract available.
Health-Promoting Properties of Lactobacillus helveticus.
Taverniti V, Guglielmetti S. Taverniti V, et al. Front Microbiol. 2012 Nov 19;3:392. doi: 10.3389/fmicb.2012.00392. eCollection 2012. Front Microbiol. 2012. PMID: 23181058 Free PMC article.
Bacterial DNAemia is associated with serum zonulin levels in older subjects.
Gargari G, Mantegazza G, Taverniti V, Del Bo' C, Bernardi S, Andres-Lacueva C, González-Domínguez R, Kroon PA, Winterbone MS, Cherubini A, Riso P, Guglielmetti S. Gargari G, et al. Among authors: taverniti v. Sci Rep. 2021 May 26;11(1):11054. doi: 10.1038/s41598-021-90476-0. Sci Rep. 2021. PMID: 34040086 Free PMC article.
Myeloid cell expressed proprotein convertase FURIN attenuates inflammation.
Cordova ZM, Grönholm A, Kytölä V, Taverniti V, Hämäläinen S, Aittomäki S, Niininen W, Junttila I, Ylipää A, Nykter M, Pesu M. Cordova ZM, et al. Among authors: taverniti v. Oncotarget. 2016 Aug 23;7(34):54392-54404. doi: 10.18632/oncotarget.11106. Oncotarget. 2016. PMID: 27527873 Free PMC article.
Cutaneous barrier leakage and gut inflammation drive skin disease in Omenn syndrome.
Rigoni R, Fontana E, Dobbs K, Marrella V, Taverniti V, Maina V, Facoetti A, D'Amico G, Al-Herz W, Cruz-Munoz ME, Schuetz C, Gennery AR, Garabedian EK, Giliani S, Draper D, Dbaibo G, Geha RS, Meyts I, Tousseyn T, Neven B, Moshous D, Fischer A, Schulz A, Finocchi A, Kuhns DB, Fink DL, Lionakis MS, Swamydas M, Guglielmetti S, Alejo J, Myles IA, Pittaluga S, Notarangelo LD, Villa A, Cassani B. Rigoni R, et al. Among authors: taverniti v. J Allergy Clin Immunol. 2020 Nov;146(5):1165-1179.e11. doi: 10.1016/j.jaci.2020.04.005. Epub 2020 Apr 18. J Allergy Clin Immunol. 2020. PMID: 32311393 Free PMC article.
47 results